| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af737d167c026fd865fb68df681ea49a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
| filingDate |
1985-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1987-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9dbd463d94f961539526c0d0ab616c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb462d4922b0a91af9aafca14b4eae6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69a0210e7bb9f7198a0a81ec92edddc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d52e25c3c4117a922895783e7c2e0124
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_662bf9d7c3bb4584fe8eb89da839d26e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98c1a783edb8cb90749e7e2b1487e39b |
| publicationDate |
1987-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-1224461-A |
| titleOfInvention |
Antibiotic compound, a method for its preparation and compositions containing it |
| abstract |
Abstract The invention relates to a new antibiotic compound, acetyl erythromycin stearate having formula I The compound according to the invention is absorbed readily from the alimentary tract. Gastric acid does not convert the compound according to the invention to an uneffective form as is the case with some other erythromycin antibiotics. Absorbing is good also when the patient eats when taking the new medicine. The compound according to the invention is prepared by reacting erythromycin base with acetyl halide in an organic solvent in the presence of an acid acceptor. The stearate salt is prepared from the obtained ester without in between isolating the ester. |
| priorityDate |
1984-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |